Akanda Corp.

Equities

AKAN

CA00971M2058

Healthcare Facilities & Services

Market Closed - Nasdaq 04:00:00 2024-04-26 pm EDT 5-day change 1st Jan Change
0.103 USD +12.57% Intraday chart for Akanda Corp. +9.11% -76.62%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Akanda Corp. Announces Board Changes CI
Akanda Corp. Announces Commercialize and Capitalize on Germany?s Legalization of Cannabis, Opening Path to $3 billion Market and Plans to Enter Blockchain and AI Technology Sector CI
Akanda Corp. Announces Strategic Plan to Evaluate and Enter Bitcoin, Blockchain, AI Segments of Cannabis Market CI
SOMAI Pharmaceuticals Inc. entered into Non-Binding Letter of Intent to acquire Rpk Biopharma, Unipessoal, Lda from Akanda Corp. for ?1.85 million. CI
Akanda Corp. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Akanda Hires Charn Deol as CFO MT
Akanda Corp. Appoints Charn Deol as Chief Financial Officer CI
Akanda Gets Nasdaq Notice on Minimum Bid Price Deficiency MT
Akanda Corp. Announces Termination of Loan Agreement CI
Akanda Terminates Loan Agreement With Veridia Canada MT
Akanda Corp. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Akanda Corp. Auditor Raises 'Going Concern' Doubt CI
Akanda Corp. Announces That It Has Entered into A Loan Agreement with Veridia Canada Ltd CI
Akanda Regains Compliance With Nasdaq Listing Requirements MT
Certain Common Shares of Akanda Corp. are subject to a Lock-Up Agreement Ending on 14-MAR-2023. CI
Akanda Plans 1-for-10 Reverse Stock Split; Shares Fall MT
North American Morning Briefing : Stock Futures -2- DJ
Akanda Names Shailesh Bhushan Finance Chief MT
Akanda Corporation Announces Appointment of Shailesh Bhushan as Chief Financial Officer CI
Akanda Corp. Announces Board Changes CI
Akanda Corp. Announces Executive Changes CI
Akanda Corp. Announces Directorate Changes CI
Top Premarket Gainers MT
Top Premarket Gainers MT
Akanda Corp. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Chart Akanda Corp.
More charts
Akanda Corp. is an international medical cannabis and wellness platform company. The Company’s portfolio includes Canmart Ltd. (CanMart), a United Kingdom-based fully licensed pharmaceutical importer and distributor which supplies pharmacies and clinics within the United Kingdom. Canmart is a licensed importer and distributor of CBD Extraction for Medicinal Purposes (CBPMs) in the United Kingdom. CanMart holds a controlled drug license issued by the Home Office to possess and supply CBPMs in the United Kingdom. The Company's seed-to-patient supply chain also includes partnerships Cellen Life Sciences' Leva Clinic, a fully digital pain clinic in the United Kingdom. The Company also develops a Canadian farming property in British Columbia, including farming land and related operations and licenses. The Company also focuses on developing tetrahydrocannabinol (THC) and cannabinoid (CBD) facilities at this site.
More about the company
  1. Stock Market
  2. Equities
  3. AKAN Stock
  4. News Akanda Corp.
  5. Akanda Terminates Loan Agreement With Veridia Canada